Egetis Therapeutics
Develops and commercializes treatments for serious and rare diseases.
EGTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0003815604
- LEI:
- 549300RZCKGWRUBPMY22
- Country:
- Sweden
- Address:
- Klara Norra Kyrkogata 26, 111 22 Stockholm
- Website:
- https://www.egetis.com/
- Sector:
- Manufacturing
Description
Egetis Therapeutics is an innovative and integrated pharmaceutical company focused on developing and commercializing treatments for serious and rare diseases with significant unmet medical needs. The company's strategy centers on advancing drug candidates through late-stage clinical development to market approval. Its primary asset, Emcitate (tiratricol), is a first-in-class drug candidate in late-stage development for the treatment of Monocarboxylate Transporter 8 (MCT8) deficiency, a rare congenital disorder of thyroid hormone transport.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-11-10 14:50 |
KALLELSE TILL EXTRA BOLAGSSTÄMMA I PLEDPHARMA AB
|
Swedish | 91.6 KB | ||
| 2020-11-07 14:19 | English | 34.3 KB | |||
| 2020-11-06 13:58 | English | 33.9 KB | |||
| 2020-11-06 10:00 |
Henrik Krook appointed VP Commercial Operations at PledPharma
|
English | 126.9 KB | ||
| 2020-11-06 10:00 |
Henrik Krook utsedd till VP Commercial Operations på PledPharma
|
Swedish | 149.3 KB | ||
| 2020-11-05 16:15 |
PledPharma publishes prospectus and updated financial information in connection…
|
English | 181.6 KB | ||
| 2020-11-05 16:15 |
PledPharma offentliggör prospekt samt uppdaterad finansiell information i samba…
|
Swedish | 180.3 KB | ||
| 2020-11-03 13:56 | English | 34.1 KB | |||
| 2020-10-28 16:10 |
Resolutions from extraordinary general meeting in PledPharma AB (publ) held on …
|
English | 77.2 KB | ||
| 2020-10-28 16:10 |
Kommuniké från extra bolagsstämma i PledPharma AB (publ) den 28 oktober 2020
|
Swedish | 112.9 KB | ||
| 2020-10-20 08:00 |
Valberedning utsedd inför årsstämman 2021 i PledPharma
|
Swedish | 99.2 KB | ||
| 2020-10-20 08:00 |
Nomination Committee appointed for the 2021 Annual General Meeting in PledPharma
|
English | 99.6 KB | ||
| 2020-10-05 08:03 |
Notice of Extraordinary general meeting in PledPharma AB
|
Swedish | 158.3 KB | ||
| 2020-10-05 08:03 |
Kallelse till extra bolagsstämma i PledPharma AB
|
Swedish | 158.3 KB | ||
| 2020-10-05 08:01 |
PledPharma carries out a fully guaranteed rights issue of approximately SEK 200…
|
English | 106.6 KB |
Automate Your Workflow. Get a real-time feed of all Egetis Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Egetis Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Egetis Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-09 | Yilmaz Mahshid | Other | Sell | 39,753 | 268,332.75 SEK |
| 2025-01-08 | Yilmaz Mahshid | Other | Sell | 98,567 | 653,499.21 SEK |
| 2025-01-07 | Yilmaz Mahshid | Other | Sell | 74,769 | 507,681.51 SEK |
| 2024-10-07 | Nicklas Westerholm | Other | Buy | 10,142 | 43,103.50 SEK |
| 2024-10-07 | Yilmaz Mahshid | Other | Buy | 10,000 | 42,250.00 SEK |
| 2023-07-07 | Henrik Krook | Other | Buy | 33,594 | 133,704.12 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 3,616 | 14,391.68 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 2,000 | 7,920.00 SEK |
| 2023-07-05 | Christian Sonesson | Other | Buy | 1,384 | 5,452.96 SEK |
| 2023-07-04 | Nicklas Westerholm | Other | Buy | 15,350 | 60,632.50 SEK |
Peer Companies
